Research programme: G protein-coupled receptor modulators - Theratechnologies

Drug Profile

Research programme: G protein-coupled receptor modulators - Theratechnologies

Alternative Names: GPCR modulators - Theratechnologies; TH 2701

Latest Information Update: 10 Jan 2007

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Theratechnologies
  • Class
  • Mechanism of Action G protein-coupled receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Diabetes mellitus

Most Recent Events

  • 15 Mar 2006 The programme is available for out-licensing(http://www.theratech.com)
  • 09 Sep 2004 A preclinical study has been added to the Diabetes pharmacodynamics section
  • 09 Sep 2003 Preclinical trials in Diabetes mellitus in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top